| Mrs Marcy Carter Kot, APRN | |
|
7301 E Frontage Rd, Merriam, KS 66204-1632 | |
| (913) 789-1940 | |
| (913) 384-4093 |
| Full Name | Mrs Marcy Carter Kot |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 16 Years |
| Location | 7301 E Frontage Rd, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427298504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 46333 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Implantable cardioverter-defibrillator use is associated with reduced short- and long-term mortality in patients with heart failure, according to late-breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.
People with cystic fibrosis are living better and longer, and now investigators want to further enhance quality and longevity by better understanding the role of nutrition, body composition and exercise in their health across an increasing lifespan.
› Verified 2 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Implantable cardioverter-defibrillator use is associated with reduced short- and long-term mortality in patients with heart failure, according to late-breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.
People with cystic fibrosis are living better and longer, and now investigators want to further enhance quality and longevity by better understanding the role of nutrition, body composition and exercise in their health across an increasing lifespan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Marcy Carter Kot, APRN 7301 E Frontage Rd, Merriam, KS 66204-1632 Ph: (913) 789-1940 | Mrs Marcy Carter Kot, APRN 7301 E Frontage Rd, Merriam, KS 66204-1632 Ph: (913) 789-1940 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
Implantable cardioverter-defibrillator use is associated with reduced short- and long-term mortality in patients with heart failure, according to late-breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.
People with cystic fibrosis are living better and longer, and now investigators want to further enhance quality and longevity by better understanding the role of nutrition, body composition and exercise in their health across an increasing lifespan.
› Verified 2 days ago
Carrie Elizabeth Tyner, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St Ste 300, Merriam, KS 66204 Phone: 913-632-2900 Fax: 913-632-2999 | |
Erica Whorton, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7450 Kessler St Ste 105, Merriam, KS 66204 Phone: 913-362-1660 Fax: 913-362-5916 | |
Jacqueline Nicole Switzer, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9301 W 74th St Ste 130, Merriam, KS 66204 Phone: 913-632-9130 Fax: 913-632-9149 | |
Heather Otwell, APRN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-676-2214 | |
Jaclyn Diane Bauer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7301 E Frontage Rd Ste 100, Merriam, KS 66204 Phone: 913-384-4040 Fax: 913-384-4093 | |
Karen Ann Wenner, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St, Suite 354, Merriam, KS 66204 Phone: 913-894-2121 Fax: 913-894-9592 | |
Catherine Mcnair, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-632-2500 |